Announcements Trials
Browse Landscape

Phase

Phase NA 9Phase 1 3Phase 2 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 3Colorectal Neoplasms 2Stage IV Breast Cancer AJCC v6 and v7 1Rectal Neoplasms 1Melanoma 1Colonic Neoplasms 1

Interventions

Docetaxel 43enzalutamide 31Prednisone 25Abiraterone Acetate 24Magnetic Resonance Spectroscopy 18abiraterone 15pembrolizumab 14bicalutamide 14Radiotherapy 14Cyclophosphamide 13darolutamide 12Leuprolide 12Goserelin 12apalutamide 10Ipilimumab 10olaparib 9Specimen Handling 9Radiosurgery 9Radiation 9Injections 9Biopsy 9Pluvicto 8Paclitaxel 8Radiotherapy, Intensity-Modulated 7Carboplatin 7sargramostim 6fludarabine 6cabazitaxel 6Sirolimus 6Nivolumab 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Prostatic Neoplasms × Diet Therapy × Clear all
NCT01823562 2026-05-20

Aborption and Metabolism of Lyophilized Black Raspberry Food Products in Men With Prostate Cancer Undergoing Surgery

Ohio State University Comprehensive Cancer Center

Phase 1 Completed
60 enrolled 12 charts
Genitourinary

Prostatic Neoplasms

NCT00082732 2018-11-06

Behavior-Based Dietary Intervention in Treating Patients With Hormone-Refractory Prostate Cancer

M.D. Anderson Cancer Center

Phase 1 Completed
56 enrolled
Genitourinary

Prostatic Neoplasms

NCT01913015 2017-04-28

Dietary Fat Levels and Abiraterone Acetate Uptake in Patients With Metastatic Hormone-Resistant Prostate Cancer

OHSU Knight Cancer Institute

Phase 1 Terminated
3 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡